EUVIMEDSkopri EUVIMED
Leserbrief

Letter: Optimising Hepatitis B Vaccination in Inflammatory Bowel Disease – Expanding Strategies Beyond Double‐Dose Recombinant Vaccination

Yash Hegde iD, Freddy Caldera iD

Alimentary Pharmacology & Therapeutics · 2026-06 · 63 (11) · 1579-1581

DOI: 10.1111/apt.70651 ↗

At a glance

Leserbrief in Alimentary Pharmacology & Therapeutics, published online on 2026-03-31. Written by Yash Hegde and 1 co-authors. Institution: Department of Medicine, University of Wisconsin - Madison, School of Medicine & Public Health, Madison, Wisconsin, USA. Cited 1 times so far (Crossref); 9 references.

AstrattDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Ebda abstract disponibbli.

Authors and institutions

  • Department of Medicine, University of Wisconsin - Madison, School of Medicine & Public Health, Madison, Wisconsin, USA.
  • Department of Medicine, Division of Gastroenterology and Hepatology, University of Wisconsin - Madison, School of Medicine & Public Health, Madison, Wisconsin, USA.

ORCID profiles: Yash Hegde, Freddy Caldera

Cite

APA

Hegde, Y., & Caldera, F. (2026). Letter: Optimising Hepatitis B Vaccination in Inflammatory Bowel Disease – Expanding Strategies Beyond Double‐Dose Recombinant Vaccination. Alimentary Pharmacology & Therapeutics, 63(11), 1579-1581. https://doi.org/10.1111/apt.70651

Vancouver

Hegde Y, Caldera F. Letter: Optimising Hepatitis B Vaccination in Inflammatory Bowel Disease – Expanding Strategies Beyond Double‐Dose Recombinant Vaccination. Alimentary Pharmacology & Therapeutics. 2026;63(11):1579-1581. doi:10.1111/apt.70651

BibTeX
@article{Hegde2026,
  author = {Hegde, Yash and Caldera, Freddy},
  title = {Letter: Optimising Hepatitis B Vaccination in Inflammatory Bowel Disease – Expanding Strategies Beyond Double‐Dose Recombinant Vaccination},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {63},
  number = {11},
  pages = {1579--1581},
  doi = {10.1111/apt.70651}
}
Start for free →